US Army Wraps Preclinical Trials on COVID-19 Vaccine Designed to Combat Variety of Variants

Initial reports claimed that scientists at the Walter Reed Army Institute of Research (WRAIR) were developing a vaccine against all variants of SARS-CoV-2, a virus that causes respiratory illness in humans. However, this appears to be only partially true, according to clarification provided by the Maryland-based biomedical research facility.